| Literature DB >> 23843689 |
Ian D Coulter1, Raheleh Khorsan, Cindy Crawford, An-Fu Hsiao.
Abstract
This article is based on an extensive review of integrative medicine (IM) and integrative health care (IHC). Since there is no general agreement of what constitutes IM/IHC, several major problems were identified that make the review of work in this field problematic. In applying the systematic review methodology, we found that many of those captured articles that used the term integrative medicine were in actuality referring to adjunctive, complementary, or supplemental medicine. The objective of this study was to apply a sensitivity analysis to demonstrate how the results of a systematic review of IM and IHC will differ according to what inclusion criteria is used based on the definition of IM/IHC. By analyzing 4 different scenarios, the authors show that, due to unclear usage of these terms, results vary dramatically, exposing an inconsistent literature base for this field.Entities:
Keywords: alternative medicine; complementary; integrative health care; integrative medicine; systematic review
Year: 2013 PMID: 23843689 PMCID: PMC3700987 DOI: 10.4137/IMI.S11570
Source DB: PubMed Journal: Integr Med Insights ISSN: 1177-3936
Figure 1Systematic review flow chart.
Studies matrix.
| Integrative title | Adjunctive title | |
|---|---|---|
| Integrative intervention | Edelman D, Oddone EZ, Liebowitz RS, Yancy WS Jr, Olsen MK, Jeffreys AS, Moon SD, Harris AC, Smith LL, Quillian-Wolever RE, Gaudet TW. A multidimensional integrative medicine intervention to improve cardiovascular risk. | Krucoff MW, Crater SW, Green CL, Maas AC, Seskevich JE, Lane JD, Loeffler KA, Morris K, Bashore TM, Koenig HG. Integrative noetic therapies as adjuncts to percutaneous intervention during unstable coronary syndromes: Monitoring and Actualization of Noetic Training (MANTRA) feasibility pilot. |
| Adjunctive intervention | Narahari SR, Aggithaya MG, Prasanna KS, Bose KS. An integrative treatment for lower limb lymphedema (elephantiasis). | Berman BM, Lao L, Langenberg P, Lee WL, Gilpin AM, Hochberg MC. Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: a randomized, controlled trial. |
Study characteristics.
| Citation | Population description | Description of intervention | Description of control | Intervention duration and time-points | Primary outcomes assessed/results | Adverse events | Sign score |
|---|---|---|---|---|---|---|---|
| 570 patients with osteoarthritis of the knee (mean age [±SD], 65.5 ± 8.4 years). | 23 true acupuncture sessions over 26 weeks gradually tapering treatment according to the following schedule: 8 weeks of 2 treatments per week followed by 2 weeks of 1 treatment per week, 4 weeks of 1 treatment every other week, and 12 weeks of 1 treatment per month. | No adverse effects were associated with acupuncture. | ++ | ||||
| 150 coronary disease patients (mean age [±SD], 63 ± ND years). | The Monitoring and Actualization of Noetic Training (MANTRA): Feasibility of applying 4 noetic therapies—stress relaxation, imagery, touch therapy, and prayer plus UC | Baseline period was defined as the period from when the patient signed the consent form to the time the patient entered the catheterization laboratory. The physiologic stress period was defined as the period beginning with the arteriotomy in the catheterization laboratory until 30 mins after the last contrast injection. The recovery period was defined as the period from 30 mins after the last contrast injection through the time of hospital discharge. Long-term follow-up was defined as 6 months from the day of the PCI. | ND | ++ | |||
| 467 Llymphatic filariasis patients (mean age [±SD], ND ± ND years). | Biomedical, Ayurvedic, and yoga medicine | ND | Baseline, 14th day, 45th day, and 90th day. | Contact dermatitis to nalpamaradi oil used for IMLD in five limbs. About 10% of patients developed scattered sterile pustules over the massaged limbs. | − | ||
| 154 cardiovascular risk outpatients (mean age [±SD], 53.4 ± 4.8 years (UC) and 52.2 ± 5.2 years (PHP)). | Baseline, 5, and 10 months | ND | + | ||||
Notes:
SIGN checklist for RCTs and controlled clinical trials; ++Strong. All or most of the criteria have been fulfilled; +Article is neither exceptionally strong nor exceptionally weak; −Weak. Few or no criteria fulfilled.
Abbreviations: NS, Not Significant; Wk(s), Week(s); Min, Minutes; Mon(s), Month(s); QOL, Quality of Life; HR, Hour; EoT, End of Treatment; SE, Side Effect; SD, Standard Deviation; ND, Not Described; DUREL, Duke University Religion Index; SAQ, Spielberger anxiety questionnaires; WOMAC, Western Ontario and McMaster Universities Arthritis Index.